BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism.
|
28257692 |
2017 |
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism.
|
28257692 |
2017 |
Teratozoospermia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, ribosomal protein S3 (RPS3), RPS5, RPS6, RPS16 and RPS23 were downregulated and enriched using KEGG in teratozoospermia.
|
29901159 |
2018 |
Microcephaly
|
0.110 |
Biomarker
|
disease |
BEFREE |
Here de novo missense mutations in the RPS23 gene, which codes for uS12, are reported in two unrelated individuals with microcephaly, hearing loss, and overlapping dysmorphic features.
|
28257692 |
2017 |
Dysmorphic features
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here de novo missense mutations in the RPS23 gene, which codes for uS12, are reported in two unrelated individuals with microcephaly, hearing loss, and overlapping dysmorphic features.
|
28257692 |
2017 |
Synovitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, the GS synovitis and PD synovitis of US12 were computed in 2 separate scores instead of 1.
|
29965853 |
2019 |
Recurrent herpes simplex infection of eye
|
0.010 |
Biomarker
|
disease |
BEFREE |
Sequential corneal isolates (n = 39) from 15 immunocompetent patients with RHK were assayed for acyclovir susceptibility and genotyped by analyzing the hypervariable regions of the HSV-1 genes US1 and US12.
|
19795980 |
2009 |
Intervertebral Disc Degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results revealed the involvement of COL3A1 in skeletal system process and RPL8, RPS16, and RPS23 in the protein synthesis processes in the progression of DD, suggesting their potential use in the diagnosis and therapy of DD.
|
25893343 |
2015 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The RPL35, RPS23 and TIMP1 genes were found to be overexpressed in both early and advanced stage colorectal adenocarcinomas (p<0.05).
|
25107436 |
2014 |
Developmental Disabilities
|
0.010 |
GeneticVariation
|
group |
BEFREE |
These discoveries describe a ribosomopathy linked to uS12 and reveal mechanistic distinctions between RP gene mutations driving hematopoietic disease and those resulting in developmental disorders.
|
28257692 |
2017 |
Bipolar Disorder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Two of these showed differential expression in the CC of BD cases: RPS23 was significantly down-regulated (p = 0.0036, fc = 0.80), while GRIN2A showed suggestive evidence of down-regulation in BD (p = 0.056, fc = 0.65).
|
31652432 |
2019 |
Herpes Simplex Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
We developed a polymerase chain reaction (PCR) method, based on strain-to-strain variation of DNA repeats in the herpes simplex virus type 2 (HSV-2) genes US1 and US12, to genotype HSV-2 strains and determine the incidence and risk factors associated with HSV-2 superinfection in patients with recurrent genital herpes (RGH).
|
16991086 |
2006 |
Superinfection
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We developed a polymerase chain reaction (PCR) method, based on strain-to-strain variation of DNA repeats in the herpes simplex virus type 2 (HSV-2) genes US1 and US12, to genotype HSV-2 strains and determine the incidence and risk factors associated with HSV-2 superinfection in patients with recurrent genital herpes (RGH).
|
16991086 |
2006 |
Recurrent genital herpes simplex
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We developed a polymerase chain reaction (PCR) method, based on strain-to-strain variation of DNA repeats in the herpes simplex virus type 2 (HSV-2) genes US1 and US12, to genotype HSV-2 strains and determine the incidence and risk factors associated with HSV-2 superinfection in patients with recurrent genital herpes (RGH).
|
16991086 |
2006 |
High-Grade Squamous Intraepithelial Lesions
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We found that population-level EVPI for conducting future clinical research evaluating HSIL management approaches was US$12 million (range $6-$20 million).
|
28807605 |
2017 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We recently identified a mouse gene, Rps23 retroposed gene 1 (Rps23rg1), that regulates beta-amyloid (Abeta) level and tau phosphorylation, two major pathological hallmarks of Alzheimer's disease (AD), and found that Rps23rg1 originated through retroposition of the mouse ribosomal protein S23 (Rps23) mRNA.
|
20650958 |
2010 |